This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
smart-health: Archive
Can Cigna's AI Push Help Rein In Rising Healthcare Costs?
by Rajshree Sipani
CI is expanding AI across care coordination and specialty pharmacy as it seeks to manage elevated healthcare costs and improve access.
CINegative Net Change UNHPositive Net Change HUMPositive Net Change
artificial-intelligence automation insurance medical smart-health
Chagee Holdings Limited - Sponsored ADR (CHA)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CHANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can Centene Sustain Its Turnaround Amid Membership Pressure?
by Rajshree Sipani
CNC's profitability is recovering, but rising margins face a key test as Medicaid membership declines and eligibility reviews continue.
CNCNegative Net Change UNHPositive Net Change HUMPositive Net Change
artificial-intelligence insurance medical smart-health
AT&T Teams Up With LifeMD for Virtual Health Care: Can it Aid Shares?
by Zacks Equity Research
T expands customer benefits with complimentary LifeMD memberships, offering virtual care, prescriptions and pharmacy services.
TPositive Net Change VZNegative Net Change TMUSPositive Net Change LFMDPositive Net Change
communications internet smart-health tech-stocks
Should You Buy PMV Pharmaceuticals, Inc. (PMVP) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PMVPPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
TTD Expands Pharma Reach: Can New Healthcare Integrations Drive Growth
by Shreya Majumder
TTD is expanding healthcare advertising with Veeva Crossix and IQVIA integrations, giving pharma advertisers more granular measurement and media optimization.
TTDNegative Net Change MGNINegative Net Change PUBMPositive Net Change
ad-tech artificial-intelligence biotechnology pharmaceuticals smart-health tech-stocks
Here's Why Tenet Healthcare Shares are Attracting Investors Now
by Zacks Equity Research
THC's shares are gaining on higher-acuity demand, strong commercial revenues and USPI's continued expansion.
THCPositive Net Change UNHPositive Net Change CNCNegative Net Change GMEDNegative Net Change
artificial-intelligence automation medical medical-devices robotics smart-health
Can Celestica's Next-Generation HealthTech Portfolio Lift Its Shares?
by Zacks Equity Research
CLS supports growing HealthTech demand with advanced manufacturing, supply chain and engineering solutions for medical devices.
CLSPositive Net Change JBLPositive Net Change SANMPositive Net Change
artificial-intelligence automation smart-health tech-stocks
KANZHUN LIMITED Sponsored ADR (BZ) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
BZNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can Centene's Medicare Advantage Strategy Unlock Better Margins?
by Zacks Equity Research
CNC is set to reshape its Medicare Advantage business around dual-eligible members and a simpler footprint to drive margin recovery.
CNCNegative Net Change UNHPositive Net Change ELVNegative Net Change
insurance medical smart-health